BOSTON, March 30, 2026 -- Aktis Oncology, Inc. (NASDAQ:AKTS) (the “Company”), a clinical-stage oncology company focused on expanding the breakthrough potential of targeted radiopharmaceuticals to large populations, including those not...
Boragen
Boragen was formed to develop synthetic fungicides based on a group of boron-containing compounds. In 2022, the company split into three separate companies, 5Metis, Borah and Reactive Biosciences.
Boragen
Research Triangle Park, NC
